AtriCure (ATRC) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.28 -0.56%
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $49.5 million versus the consensus estimate of $59.5 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Jefferies Financial Group (JEF) Misses Q2 EPS by 22c
- Qualcomm targets $40B in non-handset revenue by fiscal 2029
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
